CAR T-Cell Therapy: A Promising Modality for Autoimmune Diseases

被引:0
作者
Thakral, Deepshi [1 ]
Ramanan, Tejas [2 ]
Bagri, Narendra Kumar [3 ]
机构
[1] Dr BRAICH All India Inst Med Sci, Lab Oncol Unit, New Delhi, India
[2] Univ Birmingham, Birmingham, England
[3] All India Inst Med Sci AIIMS, Dept Pediat, Div Pediat Rheumatol, New Delhi 110029, India
关键词
Chimeric antigen receptor; Chimeric autoantibody receptor (CAAR) T-cells; Refractory; Systemic lupus erythematosus; CANCER;
D O I
10.1007/s13312-024-3300-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Chimeric Antigen Receptor (CAR) T-cells have emerged as a promising immune effector cell-based therapy. With promising results and approval for the treatment of hematological malignancies, we discuss the scope of this novel therapeutic modality in systemic autoimmune diseases and immune-mediated inflammatory disorders refractory to conventional and biological disease-modifying agents.
引用
收藏
页码:987 / 991
页数:5
相关论文
共 25 条
[1]   Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study [J].
Abramson, Jeremy S. ;
Palomba, M. Lia ;
Gordon, Leo I. ;
Lunning, Matthew A. ;
Wang, Michael ;
Arnason, Jon ;
Mehta, Amitkumar ;
Purev, Enkhtsetseg ;
Maloney, David G. ;
Andreadis, Charalambos ;
Sehgal, Alison ;
Solomon, Scott R. ;
Ghosh, Nilanjan ;
Albertson, Tina M. ;
Garcia, Jacob ;
Kostic, Ana ;
Mallaney, Mary ;
Ogasawara, Ken ;
Newhall, Kathryn ;
Kim, Yeonhee ;
Li, Daniel ;
Siddiqi, Tanya .
LANCET, 2020, 396 (10254) :839-852
[2]   The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma [J].
Ali, Sahra ;
Kjeken, Rune ;
Niederlaender, Christiane ;
Markey, Greg ;
Saunders, Therese S. ;
Opsata, Mona ;
Moltu, Kristine ;
Bremnes, Bjorn ;
Gronevik, Eirik ;
Muusse, Martine ;
Hakonsen, Gro D. ;
Skibeli, Venke ;
Kalland, Maria Elisabeth ;
Wang, Ingrid ;
Buajordet, Ingebjorg ;
Urbaniak, Ania ;
Johnston, John ;
Rantell, Khadija ;
Kerwash, Essam ;
Schuessler-Lenz, Martina ;
Salmonson, Tomas ;
Bergh, Jonas ;
Gisselbrecht, Christian ;
Tzogani, Kyriaki ;
Papadouli, Irene ;
Pignatti, Francesco .
ONCOLOGIST, 2020, 25 (02) :E321-E327
[3]   AUTOIMMUNE DISEASE IS THE NEXT FRONTIER FOR CAR T CELL THERAPY [J].
Arnold, Carrie .
NATURE MEDICINE, 2024, 30 (01) :6-9
[4]  
Asthana S., 2018, PEDIAT HEMATOL ONCOL, V3, P115, DOI [10.1016/j.phoj.2017.12.004, DOI 10.1016/J.PHOJ.2017.12.004]
[5]   CAR-T cell manufacturing: Major process parameters and next-generation strategies [J].
Ayala Ceja, Melanie ;
Khericha, Mobina ;
Harris, Caitlin M. ;
Puig-Saus, Cristina ;
Chen, Yvonne Y. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2024, 221 (02)
[6]   Defining 'T cell exhaustion' [J].
Blank, Christian U. ;
Haining, W. Nicholas ;
Held, Werner ;
Hogan, Patrick G. ;
Kallies, Axel ;
Lugli, Enrico ;
Lynn, Rachel C. ;
Philip, Mary ;
Rao, Anjana ;
Restifo, Nicholas P. ;
Schietinger, Andrea ;
Schumacher, Ton N. ;
Schwartzberg, Pamela L. ;
Sharpe, Arlene H. ;
Speiser, Daniel E. ;
Wherry, E. John ;
Youngblood, Benjamin A. ;
Zehn, Dietmar .
NATURE REVIEWS IMMUNOLOGY, 2019, 19 (11) :665-674
[7]   Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma [J].
Costa, Bruno Almeida ;
Flynn, Jessica ;
Nishimura, Noriko ;
Devlin, Sean M. ;
Farzana, Tasmin ;
Rajeeve, Sridevi ;
Chung, David J. ;
Landau, Heather J. ;
Lahoud, Oscar B. ;
Scordo, Michael ;
Shah, Gunjan L. ;
Hassoun, Hani ;
Maclachlan, Kylee ;
Hultcrantz, Malin ;
Korde, Neha ;
Lesokhin, Alexander M. ;
Shah, Urvi A. ;
Tan, Carlyn R. ;
Giralt, Sergio A. ;
Usmani, Saad Z. ;
Nath, Karthik ;
Mailankody, Sham .
BLOOD CANCER JOURNAL, 2024, 14 (01)
[8]   CAR-T cell manufacturing landscape-Lessons from the past decade and considerations for early clinical development [J].
Dias, Juliana ;
Garcia, John ;
Agliardi, Giulia ;
Roddie, Claire .
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (02)
[9]   Design and development of therapies using chimeric antigen receptor-expressing T cells [J].
Dotti, Gianpietro ;
Gottschalk, Stephen ;
Savoldo, Barbara ;
Brenner, Malcolm K. .
IMMUNOLOGICAL REVIEWS, 2014, 257 (01) :107-126
[10]   Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease [J].
Ellebrecht, Christoph T. ;
Bhoj, Vijay G. ;
Nace, Arben ;
Choi, Eun Jung ;
Mao, Xuming ;
Cho, Michael Jeffrey ;
Di Zenzo, Giovanni ;
Lanzavecchia, Antonio ;
Seykora, John T. ;
Cotsarelis, George ;
Milone, Michael C. ;
Payne, Aimee S. .
SCIENCE, 2016, 353 (6295) :179-184